AERINAZE 2.5mg / 120mg modified release film tablets medication leaflet

R01BA52 desloratadine + pseudoephedrine • Respiratory system | Nasal decongestants for systemic use | Sympathomimetics

Desloratadine + pseudoephedrine is a combination medication used to treat symptoms of seasonal allergic rhinitis accompanied by severe nasal congestion. This combination combines the effects of an antihistamine and a decongestant:

- Desloratadine is a second-generation antihistamine that blocks H1 histamine receptors, reducing allergy symptoms such as sneezing, itching, and nasal discharge.
- Pseudoephedrine is a decongestant that works by constricting blood vessels in the nasal mucosa, reducing congestion and improving breathing.

This combination is indicated for patients who experience both allergy symptoms and nasal congestion, providing comprehensive symptom relief.

Side effects may include dry mouth, dizziness, insomnia, palpitations, nervousness, or, in rare cases, severe allergic reactions. It is important to take the medication as prescribed by a doctor, and patients with high blood pressure, cardiovascular diseases, or other chronic conditions should consult their doctor before use.

General data about AERINAZE 2.5mg / 120mg

Substance: desloratadine + pseudoephedrine

Date of last drug list: 01-03-2022

Commercial code: W59831004

Concentration: 2.5mg / 120mg

Pharmaceutical form: modified release film tablets

Quantity: 10

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for desloratadine + pseudoephedrine

Other substances similar to desloratadine + pseudoephedrine